Lorem ipsum dolor sit amet:

24h / 365days

We offer support for our customers

Mon - Fri 8:00am - 5:00pm (GMT +1)

Get in touch

Cybersteel Inc.
376-293 City Road, Suite 600
San Francisco, CA 94102

Have any questions?
+44 1234 567 890

Drop us a line

About us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec.

Have any Questions? +49 33 767 - 791 10

Seramun News

Successful registration in China of SeraSpot® Vaskulitis-3 IgG

Seramun Diagnostica is proud to announce that the IvD device SeraSpot® Vaskulitis-3 IgG was successfully registered for the Chinese market after a registration period of 4 years. We would like to thank our partner R-Biopharm China and especially YiChen Wang for the continuous support. This kit is used for the detection of autoantibodies of the IgG isotype directed against the following antigens: Proteinase 3 (PR3), myeloperoxidase (MPO) and glomerular basement membrane (GBM) in human serum samples. To find out more, visit the website of our official distributor R-Biopharm AG

Minister Steinbach visits Seramun Diagnostica

Heidesee, 24.08.2020

Brandenburg's Minister of Economic Affairs Jörg Steinbach (SPD) visited the biotechnology company Seramun Diagnostica at its location in Heidesee, Germany last Monday. The company started the development of recombinant proteins, specific antibodies and laboratory tests for the detection of the SARS-CoV-2 virus in the end of March 2020. The current project status was of particular interest for Steinbach. At the moment, the company focuses on the development of laboratory tests for serological detection of antibodies against various viral components. These special laboratory tests could be used to detect potentially neutralizing antibodies and the course of infection of a Covid-19 infection, in particular with the objective of being able to distinguish a natural infection from vaccine immunization in the later course of the pandemic.

Another focus of the company is the supply of special reagents. These are fundamental for the production of laboratory tests which are being used for the detection of Sars-CoV-2. To expand production capacities, a new production building is being built since February 2020. Steinbach also visited the construction site of this new production building. Seramun Diagnostica is investing about ten million euros in the new building and is supported by the state of Brandenburg with about one million euros.

© Copyright 2001 - 2023   Seramun Diagnostica GmbH. All Rights Reserved.